-The Hindu   A Central team of the National Rural Health Mission (NRHM) has praised the implementation of various health care and nutrition schemes in Rajasthan and expressed hope that the constant decline in infant and maternal mortality rates would help improve the status of health indicators in the State. The 12-member team, divided into two sub-groups, visited Chittorgarh and Barmer districts and reviewed the progress of initiatives taken under the NRHM, mid-day...

India’s new pharmaceutical policy seeks to bring at least 400 Essential medicines—or 60% of the drugs sold in the country—under the government’s pricing control. The department of pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of Essential medicines, laying down new rules governing drug pricing. Currently, the government controls the prices of only 34 Essential medicines. The draft says the policy, to be finalized...

With institutional healthcare being prohibitively expensive, more women in rural India are choosing to deliver at home than in hospitals and healthcare facilities, says a new report brought out by Chittorgarh-based NGO, Prayas, in partnership with Oxfam India. The 'Study of the trends in out-of-pocket payments in healthcare during National Rural Health Mission period (2005-2010)', released on October 12 in the national capital, was conducted across five Indian states - Assam,...

Economic status, education, access to clean water and sanitation, nutrition and the environment determine the level of health of persons, communities or countries, and so does the extent to which rights are enjoyed or denied. The World Conference on Social Determinants of Health, held Oct. 19-21 in Brazil, defined 15 commitments that should be undertaken by governments, international organisations, the private sector and civil society.  The final document, the Rio Political Declaration...

Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...